MedPath

"Comparison of two nonchannelled videolaryngoscopes with standard direct laryngoscope for endotracheal intubation in adult patients undergoing elective surgery."

Not Applicable
Recruiting
Conditions
Adult patients (18-65)years of either gender with ASA grade I and II
Registration Number
CTRI/2018/03/012835
Lead Sponsor
Vardhman Mahavir Medical College and Safdarjung Hospital New Delhi
Brief Summary

1. To comparatively evaluate the first attempt success rate for endotracheal intubation using direct Macintosh laryngoscope or Videolaryngoscope in patients undergoing elective surgery.

2. To comparatively evaluate the modified Cormac-Lehane view, time and ease of laryngoscopy and intubation.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
180
Inclusion Criteria

ASA grade I and II, having BMI ≤30kg/m2 and standard airway parameters within normal range, scheduled for elective surgery under general anaesthesia requiring endotracheal intubation.

Exclusion Criteria
  • Patients who have anticipated difficult airway and modified Mallampati class III or IV 2.
  • Haemodynamic instability, hypertion, morbid obesity, cardiac, renal, hepatic, endocrine, pulmonary dysfunction, upper respiratory tract infection.
  • Cervical spine instability.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To comparatively evaluate the first attempt success rate for endotracheal intubationAt the time of intubation.
Secondary Outcome Measures
NameTimeMethod
To comparatively eveluate the modified Cormac-Lehane view, time and ease of laryngoscopy and intubationAt the time of intubation.

Trial Locations

Locations (1)

Vardhman Mahavir Medical College and Safdarjung Hospital.

🇮🇳

Delhi, DELHI, India

Vardhman Mahavir Medical College and Safdarjung Hospital.
🇮🇳Delhi, DELHI, India
Dr Prachi Abhyankar
Principal investigator
7838893005
prachiabhyankar24@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.